About Rajkumari Saxena

Rajkumari started her career as a writer but gradually shifted her focus to financial journalism, leveraging her educational background in Commerce. Fascinated by the interplay of business and economic shifts in equities, she aspires to evolve as an analyst. With a knack for simplifying complex financial concepts, her mission is to empower investors with insights that lead to profitable decisions.


Recent Articles By Rajkumari Saxena

: PINS |  News, Ratings, and Charts

Is Pinterest a Buy as Social Media Landscape Shifts?

Pinterest (PINS) delivered robust second-quarter results supported by strong revenue growth and continuous innovations. While its long-term outlook appears positive with increasing worldwide internet usage, it faces slow quarterly active user growth compared to the prior quarters. So, let’s determine whether Pinterest is a buy amid social media landscape shifts. Read more to find out...
: EPD |  News, Ratings, and Charts

3 High-Yield Energy Stocks to Power Your Portfolio

Oil and gas prices are evolving rapidly with changing supply levels owing to geopolitical tensions, increasing M&A activities, and robust energy demand, creating tailwinds for the energy sector. Thus, energy stocks Cheniere Energy Partners (CQP), Enterprise Products Partners (EPD), and MPLX LP (MPLX), which are also high-yielding, could be ideal investments. Read more…
: TSM |  News, Ratings, and Charts

3 Emerging Market Stocks for High-Risk, High-Reward Investors

With rapid expansion and high growth prospects, emerging markets and economies are poised to experience robust growth. Therefore, it could be wise to invest in high-risk, high rewarding emerging market stocks Taiwan Semiconductor Manufacturing (TSM), PDD Holdings (PDD), and Alibaba Group Holding (BABA). Keep reading...
: DAC |  News, Ratings, and Charts

Is Now the Right Time to Invest in Danaos Corporation?

Danaos Corporation (DAC) beat analysts’ estimates on the top and bottom lines in the second quarter of 2024. Factors like leading industry position, strategic arrangements, and solid financial performance are key drivers of the company’s continued growth. So, let’s determine whether Danaos Corporation is an ideal addition to your portfolio. Read more to find out...
: UPST |  News, Ratings, and Charts

Is Upstart a Buy as AI Transforms Lending?

Upstart Holdings (UPST) second-quarter results beat analysts’ expectations. While the company’s long-term outlook appears rosy with continuous technological innovation, it faces challenges with profitability and operational efficiency in the near term. So, should you buy Upstart as AI transform lending? Read more to find out...
: VUG |  News, Ratings, and Charts

3 ETFs for a Balanced Growth and Income Portfolio

Investing in ETFs that hold companies with high income and provide long-term growth have significant potential and can effectively diversify the portfolio. Thus, it could be wise to invest in robust tech equities ETFs Vanguard Growth Index Fund ETF Shares (VUG), Vanguard Dividend Appreciation Index Fund ETF Shares (VIG), and Schwab U.S. Dividend Equity ETF (SCHD) for potential gains. Read more...
: OLLI |  News, Ratings, and Charts

Is Ollie’s Bargain Outlet a Retail Stock to Watch?

Ollie’s Bargain (OLLI) reported its financial results for the first quarter of 2024. While the specialty retailer’s long-term outlook appears bright with strategic investment and store network expansion, it faces rigid competition and elevated valuation. So, should you buy or keep the stock on hold? Read more to find out...
: LLY |  News, Ratings, and Charts

3 Gene-Editing Stocks to Buy for Future Health Advances

With ever-expanding operations and rapid technological innovations, the gene-editing industry looks poised for solid long-term growth. Thus, investors could consider solid stocks Eli Lilly (LLY), Sanofi (SNY), and Vertex Pharmaceuticals (VRTX). Continue reading...
: IBB |  News, Ratings, and Charts

3 Biotech ETFs for a Diversified Portfolio

The biotech industry is growing rapidly with solid advancements, and ETFs in this sector can offer great investment opportunities. Thus, it could be wise to invest in top biotech ETFs SPDR S&P Biotech ETF (XBI), VanEck Biotech ETF (BBH), and iShares Biotechnology ETF (IBB) for a diversified portfolio. Read on...
: QYLD |  News, Ratings, and Charts

3 Must-Have ETFs for Income Investors

Dividend-paying ETFs are ideal for income investors as they provide regular income through dividends while offering diversification across multiple stocks, reducing risk. Therefore, investors could consider Global X NASDAQ 100 Covered Call ETF (QYLD), Invesco S&P 500 High Dividend Low Volatility ETF (SPHD), and Global X SuperDividend U.S. ETF (DIV) for steady returns. Read more...
Page generated in 1.3246 seconds.